LON:GENI GENinCode (GENI) Share Price, News & Analysis GBX 1.24 -0.01 (-1.12%) As of 03:13 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock About GENinCode Stock (LON:GENI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GENinCode alerts:Sign Up Key Stats Today's Range 1.20▼ 1.3050-Day Range 1▼ 1.3452-Week Range 0.90▼ 5.50Volume2.79 million shsAverage Volume6.10 million shsMarket Capitalization£8.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset. Read More Receive GENI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GENinCode and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GENI Stock News HeadlinesGENinCode slumps after it reprices optionsMay 7, 2026 | uk.finance.yahoo.comAIM Market Roundup: Phoenix Copper, Pipehawk, GenincodeFebruary 25, 2026 | uk.finance.yahoo.comThe SpaceX S-1 changes everythingSpaceX just filed its IPO paperwork. And buried inside that filing was something that should change how every investor thinks about this opportunity. SpaceX holds $1.45 billion in Bitcoin. Bought at an average of $35,000 per coin. Never sold a single one… not through crashes, not through balance sheet pressure, not through anything. This is a company that made a deliberate, long-term bet on digital assets… and then took it public for the entire world to see. | Crypto 101 Media (Ad)GENinCode Raises £4.1m Following Completion of WRAP Retail OfferJanuary 26, 2026 | tipranks.comTRADING UPDATES: GENinCode to raise funds via placing and subscriptionJanuary 21, 2026 | lse.co.ukGENinCode Opens WRAP Retail Offer Alongside £3.5m Placing at Deep DiscountJanuary 21, 2026 | tipranks.comGENinCode collaborates with Sohin Genetics for heart disease testDecember 17, 2025 | lse.co.ukAIM WINNERS & LOSERS: GENinCode strikes deal; Metals One fallsDecember 4, 2025 | lse.co.ukSee More Headlines GENI Stock Analysis - Frequently Asked Questions How have GENI shares performed this year? GENinCode's stock was trading at GBX 2.50 at the beginning of the year. Since then, GENI stock has decreased by 50.0% and is now trading at GBX 1.25. How were GENinCode's earnings last quarter? GENinCode Plc (LON:GENI) issued its quarterly earnings data on Tuesday, September, 30th. The company reported ($1.19) EPS for the quarter. GENinCode had a negative net margin of 170.49% and a negative trailing twelve-month return on equity of 262.16%. How do I buy shares of GENinCode? Shares of GENI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of GENinCode own? Based on aggregate information from My MarketBeat watchlists, some other companies that GENinCode investors own include Qualcomm (QCOM), Sound Energy (SOU), Zura Bio (ZURA), Capital One Financial (COF), Lincoln National (LNC), Ovid Therapeutics (OVID) and Plug Power (PLUG). Company Calendar Last Earnings9/30/2025Today6/04/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryEntertainment Current SymbolLON:GENI CIKN/A Webwww.genincode.com Phone44 1865 955 847FaxN/AEmployees2,300Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (2.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£6.10 million Net Margins-170.49% Pretax MarginN/A Return on Equity-262.16% Return on Assets-63.99% Debt Debt-to-Equity Ratio7.17 Current Ratio2.80 Quick Ratio15.89 Sales & Book Value Annual Sales£2.91 million Price / Sales3.08 Cash FlowGBX 1.48 per share Price / Cash Flow0.83 Book ValueGBX 1.63 per share Price / Book0.76Miscellaneous Outstanding Shares725,027,000Free FloatN/AMarket Cap£8.96 million OptionableNot Optionable Beta0.61 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (LON:GENI) was last updated on 6/4/2026 by MarketBeat.com Staff. From Our PartnersA gold storm is coming – are you ready?The U.S. Treasury Secretary is betting big on gold - and the world's most successful investors are following s...Traders Agency | SponsoredThe SpaceX S-1 changes everythingSpaceX just filed its IPO paperwork. And buried inside that filing was something that should change how every ...Crypto 101 Media | SponsoredHow to claim a stake in SpaceX before the June 12 IPOSpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredOil is settling in yuan now - here's what that means for goldSaudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...Golden Portfolio | SponsoredThe chokepoint supplier behind SpaceX's $1.75 trillion empireWhen Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession...Behind the Markets | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENinCode Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GENinCode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
